BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
calcium channel activity
,
Obesity
,
Liver
,
Laryngoscope
,
Vitamin E
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphodiesterase type-5 inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for phosphodiesterase type-5 inhibitors
Explore Curated Studies Results
Literature
Most Relevant Literature
PDE5 inhibitor drugs for use in dementia.
Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health.
Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism…
PDE5 inhibitors and male reproduction: Is there a place for PDE5 inhibitors in infertility clinics o…
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Dis…
Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ